About: Infection Prevention in Pediatric Oncology and Hematopoietic Stem Cell Transplant Recipients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Infection Prevention in Pediatric Oncology and Hematopoietic Stem Cell Transplant Recipients Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Infection Prevention in Pediatric Oncology and Hematopoietic Stem Cell Transplant Recipients
Creator	Flores, Ricardo Dutta, A Dutta, Ankhi Flores, R
Source	PMC
abstract	Pediatric patients with malignancies and transplant recipients are at high risk of infection-related morbidity and mortality. Children at the highest risk for infections are those with acute myeloid leukemia (AML), relapsed acute lymphoblastic leukemia (ALL), and hematopoietic stem cell transplant recipients (HSCT). These patients are at high risk for life-threatening bacterial, viral, and fungal infections which are associated with prolonged hospital stay, poor quality of life, and increased healthcare cost and death. Recognition of risk factors which predisposes them to infections, early identification of signs and symptoms of infections, prompt diagnosis, and empiric/definitive treatment are the mainstay in reducing infection-related morbidity and mortality. Infection control and prevention programs also play a crucial role in preventing hospital-acquired infections in these immunosuppressed hosts.
has issue date	2018-07-16(xsd:dateTime)
bibo:doi	10.1007/978-3-319-98122-2_16
has license	no-cc
sha1sum (hex)	b5e0a35e4d817abc3b4a1ec6d152ce82a7ca9ea9
schema:url	https://doi.org/10.1007/978-3-319-98122-2_16
resource representing a document's title	Infection Prevention in Pediatric Oncology and Hematopoietic Stem Cell Transplant Recipients
has PubMed Central identifier	PMC7122566
schema:publication	Healthcare-Associated Infections in Children
resource representing a document's body	covid:b5e0a35e4d817abc3b4a1ec6d152ce82a7ca9ea9#body_text
is schema:about of	named entity 'INFECTION PREVENTION' named entity 'hematopoietic stem cell' named entity 'Thus' named entity 'Hematopoietic' named entity 'RECOMMENDED' named entity 'VISITS' named entity 'TRANSPLANT RECIPIENTS' named entity 'INTERVENTIONS' named entity 'SETTINGS' named entity 'INFECTION CONTROL' named entity 'TREATMENT' named entity 'UNDERLYING' named entity 'ADHERENCE' named entity 'MEDICATIONS' named entity 'HEALTHCARE' named entity 'DUE TO' named entity 'TO REDUCE' named entity 'INFECTIONS' named entity 'RISK OF' named entity 'FREQUENT' named entity 'ORGANISMS' named entity 'PEDIATRIC ONCOLOGY' named entity 'PATIENTS' named entity 'STEM CELL TRANSPLANT' named entity 'THEIR' named entity 'RISK' named entity 'MALIGNANCIES' named entity 'RESISTANT' named entity 'SPECIAL POPULATION' named entity 'INCREASE' named entity 'ASSOCIATED WITH' named entity 'HEMATOPOIETIC STEM CELL' named entity 'EXPOSURE TO' named entity 'RECEIPT' named entity 'DIAGNOSES' named entity 'ESSENTIAL' named entity 'STEM CELL TRANSPLANT' named entity 'PART OF' named entity 'HOSPITALIZED CHILDREN' named entity 'ADDITION' named entity 'HEMATOPOIETIC STEM CELL' named entity 'ASSOCIATED' named entity 'ADDITIONAL' named entity 'IMMUNOSUPPRESSIVE' named entity 'INCREASED RISK' named entity 'CHILDREN' named entity 'PREVENTION MEASURES' named entity 'MORBIDITY' named entity 'immunosuppressive medications' named entity 'transplant' named entity 'risk' named entity 'frequent' named entity 'morbidity' named entity 'infection control' named entity 'Hematopoietic Stem Cell Transplant' named entity 'Infection Prevention' named entity 'blood culture' named entity 'empiric antibiotic therapy' named entity 'oncology' named entity 'caspofungin' named entity 'toxicity' named entity 'itraconazole' named entity 'measles, mumps' named entity 'IDSA' named entity 'immunocompromised' named entity 'PHO' named entity 'air crescent sign' named entity 'neutropenia' named entity 'gram-negative bacteria' named entity 'higher risk' named entity 'intravenous antibiotics' named entity 'antifungal' named entity 'immunocompromised patients' named entity 'risk factor' named entity 'oncology' named entity 'positive test' named entity 'vinca alkaloids' named entity 'A. flavus' named entity 'antifungal' named entity 'bioavailability'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software